The inferior vena cava filters market size has grown strongly in recent years. It will grow from $5.79 billion in 2025 to $6.29 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing incidence of venous thromboembolism, growth in surgical interventions, rising use of interventional radiology procedures, expansion of hospital-based vascular care, increased awareness of pulmonary embolism risks.
The inferior vena cava filters market size is expected to see strong growth in the next few years. It will grow to $8.87 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing demand for advanced retrievable filters, rising focus on post-implantation monitoring, expansion of minimally invasive treatment adoption, growing elderly population with clotting risks, technological improvements in filter design. Major trends in the forecast period include increasing adoption of retrievable ivc filters, rising use of non-ferromagnetic materials, growing preference for minimally invasive implantation techniques, expansion of temporary filter applications, enhanced focus on patient safety and retrieval rates.
The increasing preference for non-invasive or minimally invasive procedures is expected to drive the growth of the inferior vena cava (IVC) filter market going forward. Minimally invasive procedures are medical interventions designed to limit disruption to normal anatomical structures and reduce recovery time. The shift toward minimally invasive approaches is driven by both patients and clinicians seeking safer, quicker, and less painful treatment options. Inferior vena cava filters align with this trend by providing a minimally invasive solution to prevent blood-clot-related complications in patients at risk of deep vein thrombosis or pulmonary embolism. For instance, in September 2025, according to the American Society of Plastic Surgeons, a U.S.-based professional organization, minimally invasive cosmetic procedures reached 28.5 million in 2024, representing a 3% increase compared to 2023, with neuromodulator injections alone accounting for 9.9 million procedures. Therefore, the growing preference for non-invasive or minimally invasive procedures is contributing to the growth of the inferior vena cava filter market.
The rise in surgical procedures is expected to propel the growth of the inferior vena cava (IVC) filters market going forward. Surgical procedures refer to medical operations aimed at diagnosing, treating, and preventing health issues through physical modifications to tissues and organs. The increase in surgical procedures is primarily attributed to technological advancements in medicine, an expanding elderly demographic, and a higher incidence of chronic health conditions. The surge in surgical procedures boosts the inferior vena cava (IVC) filters market by driving the need for these devices, which are essential for preventing blood clots during and following surgical operations. For instance, in September 2023, according to the data from the American Society of Plastic Surgeons (ASPS), a US-based non-profit organization, estimated that the total number of cosmetic surgery procedures increased to 1,575,244 in 2023, marking a 5% rise compared to 1,498,361 procedures in 2022. Therefore, the rise in surgical procedures is driving the inferior vena cava (IVC) filters market.
In September 2024, Merit Medical Systems Inc., a US-based healthcare technology company, acquired Cook Medical’s lead management portfolio for approximately US$210 million. Through this acquisition, Merit aimed to strengthen its electrophysiology and cardiac rhythm management (CRM) business by adding a differentiated, end-to-end lead management product line. Cook Medical is a US-based medical device manufacturer that provides inferior vena cava (IVC) filters.
Major companies operating in the inferior vena cava filters market are B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical LLC, Medtronic plc, Teleflex Incorporated, Merit Medical Systems Inc., Argon Medical Devices Inc., Lifetech Scientific Corporation, Cordis Corporation, Becton Dickinson and Company, C. R. Bard Inc., Penumbra Inc., Terumo Corporation, Getinge AB, Philips Healthcare, Abbott Laboratories, AngioDynamics Inc., Endologix LLC, MicroPort Scientific Corporation, Stryker Corporation.
North America was the largest region in the inferior vena cava filters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inferior vena cava filters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the inferior vena cava filters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the inferior vena cava filters market by increasing costs of imported medical-grade metals, precision machining components, delivery systems, and sterilization equipment. Hospitals and surgical centers in North America and Europe are most affected due to dependence on imported devices and components, while Asia-Pacific faces cost pressures in export manufacturing. These tariffs are raising device prices and affecting procurement decisions. At the same time, they are encouraging local manufacturing, regional sourcing of biomaterials, and investments in domestic medical device production capabilities.
The inferior vena cava filters market research report is one of a series of new reports that provides inferior vena cava filters market statistics, including inferior vena cava filters industry global market size, regional shares, competitors with a inferior vena cava filters market share, detailed inferior vena cava filters market segments, market trends and opportunities, and any further data you may need to thrive in the inferior vena cava filters industry. This inferior vena cava filters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An inferior vena cava filter is a small device designed to prevent blood clots from reaching the lungs through the inferior vena cava, a large vein in the body. The inferior vena cava is responsible for returning deoxygenated blood to the heart and lungs. The inferior vena cava filter acts as a barrier, capturing any blood clots that may pass through and preventing them from reaching the heart or lungs.
The main product types of inferior vena cava filters include retrievable inferior vena cava (IVC) filters and permanent inferior vena cava (IVC) filters. Retrievable IVC filters allow percutaneous removal when the risk of blood clot resolves. These filters are made from various materials, including non-ferromagnetic and ferromagnetic materials. They are used in various applications such as the treatment of venous thromboembolism (VTE), prevention of pulmonary embolism (PE), and other relevant medical uses. The devices are typically employed by hospitals, ambulatory surgical centers, and other healthcare facilities.
The inferior vena cava filters market consists of sales of resorbable IVC filters, Polydioxanone (PPDO) IVC filters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The inferior vena cava filters market size is expected to see strong growth in the next few years. It will grow to $8.87 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing demand for advanced retrievable filters, rising focus on post-implantation monitoring, expansion of minimally invasive treatment adoption, growing elderly population with clotting risks, technological improvements in filter design. Major trends in the forecast period include increasing adoption of retrievable ivc filters, rising use of non-ferromagnetic materials, growing preference for minimally invasive implantation techniques, expansion of temporary filter applications, enhanced focus on patient safety and retrieval rates.
The increasing preference for non-invasive or minimally invasive procedures is expected to drive the growth of the inferior vena cava (IVC) filter market going forward. Minimally invasive procedures are medical interventions designed to limit disruption to normal anatomical structures and reduce recovery time. The shift toward minimally invasive approaches is driven by both patients and clinicians seeking safer, quicker, and less painful treatment options. Inferior vena cava filters align with this trend by providing a minimally invasive solution to prevent blood-clot-related complications in patients at risk of deep vein thrombosis or pulmonary embolism. For instance, in September 2025, according to the American Society of Plastic Surgeons, a U.S.-based professional organization, minimally invasive cosmetic procedures reached 28.5 million in 2024, representing a 3% increase compared to 2023, with neuromodulator injections alone accounting for 9.9 million procedures. Therefore, the growing preference for non-invasive or minimally invasive procedures is contributing to the growth of the inferior vena cava filter market.
The rise in surgical procedures is expected to propel the growth of the inferior vena cava (IVC) filters market going forward. Surgical procedures refer to medical operations aimed at diagnosing, treating, and preventing health issues through physical modifications to tissues and organs. The increase in surgical procedures is primarily attributed to technological advancements in medicine, an expanding elderly demographic, and a higher incidence of chronic health conditions. The surge in surgical procedures boosts the inferior vena cava (IVC) filters market by driving the need for these devices, which are essential for preventing blood clots during and following surgical operations. For instance, in September 2023, according to the data from the American Society of Plastic Surgeons (ASPS), a US-based non-profit organization, estimated that the total number of cosmetic surgery procedures increased to 1,575,244 in 2023, marking a 5% rise compared to 1,498,361 procedures in 2022. Therefore, the rise in surgical procedures is driving the inferior vena cava (IVC) filters market.
In September 2024, Merit Medical Systems Inc., a US-based healthcare technology company, acquired Cook Medical’s lead management portfolio for approximately US$210 million. Through this acquisition, Merit aimed to strengthen its electrophysiology and cardiac rhythm management (CRM) business by adding a differentiated, end-to-end lead management product line. Cook Medical is a US-based medical device manufacturer that provides inferior vena cava (IVC) filters.
Major companies operating in the inferior vena cava filters market are B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical LLC, Medtronic plc, Teleflex Incorporated, Merit Medical Systems Inc., Argon Medical Devices Inc., Lifetech Scientific Corporation, Cordis Corporation, Becton Dickinson and Company, C. R. Bard Inc., Penumbra Inc., Terumo Corporation, Getinge AB, Philips Healthcare, Abbott Laboratories, AngioDynamics Inc., Endologix LLC, MicroPort Scientific Corporation, Stryker Corporation.
North America was the largest region in the inferior vena cava filters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inferior vena cava filters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the inferior vena cava filters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the inferior vena cava filters market by increasing costs of imported medical-grade metals, precision machining components, delivery systems, and sterilization equipment. Hospitals and surgical centers in North America and Europe are most affected due to dependence on imported devices and components, while Asia-Pacific faces cost pressures in export manufacturing. These tariffs are raising device prices and affecting procurement decisions. At the same time, they are encouraging local manufacturing, regional sourcing of biomaterials, and investments in domestic medical device production capabilities.
The inferior vena cava filters market research report is one of a series of new reports that provides inferior vena cava filters market statistics, including inferior vena cava filters industry global market size, regional shares, competitors with a inferior vena cava filters market share, detailed inferior vena cava filters market segments, market trends and opportunities, and any further data you may need to thrive in the inferior vena cava filters industry. This inferior vena cava filters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An inferior vena cava filter is a small device designed to prevent blood clots from reaching the lungs through the inferior vena cava, a large vein in the body. The inferior vena cava is responsible for returning deoxygenated blood to the heart and lungs. The inferior vena cava filter acts as a barrier, capturing any blood clots that may pass through and preventing them from reaching the heart or lungs.
The main product types of inferior vena cava filters include retrievable inferior vena cava (IVC) filters and permanent inferior vena cava (IVC) filters. Retrievable IVC filters allow percutaneous removal when the risk of blood clot resolves. These filters are made from various materials, including non-ferromagnetic and ferromagnetic materials. They are used in various applications such as the treatment of venous thromboembolism (VTE), prevention of pulmonary embolism (PE), and other relevant medical uses. The devices are typically employed by hospitals, ambulatory surgical centers, and other healthcare facilities.
The inferior vena cava filters market consists of sales of resorbable IVC filters, Polydioxanone (PPDO) IVC filters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Inferior Vena Cava Filters Market Characteristics
3. Inferior Vena Cava Filters Market Supply Chain Analysis
4. Global Inferior Vena Cava Filters Market Trends and Strategies
5. Inferior Vena Cava Filters Market Analysis of End Use Industries
7. Global Inferior Vena Cava Filters Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Inferior Vena Cava Filters Total Addressable Market (TAM) Analysis for the Market
9. Inferior Vena Cava Filters Market Segmentation
10. Inferior Vena Cava Filters Market Regional and Country Analysis
11. Asia-Pacific Inferior Vena Cava Filters Market
12. China Inferior Vena Cava Filters Market
13. India Inferior Vena Cava Filters Market
14. Japan Inferior Vena Cava Filters Market
15. Australia Inferior Vena Cava Filters Market
16. Indonesia Inferior Vena Cava Filters Market
17. South Korea Inferior Vena Cava Filters Market
18. Taiwan Inferior Vena Cava Filters Market
19. South East Asia Inferior Vena Cava Filters Market
20. Western Europe Inferior Vena Cava Filters Market
21. UK Inferior Vena Cava Filters Market
22. Germany Inferior Vena Cava Filters Market
23. France Inferior Vena Cava Filters Market
24. Italy Inferior Vena Cava Filters Market
25. Spain Inferior Vena Cava Filters Market
26. Eastern Europe Inferior Vena Cava Filters Market
27. Russia Inferior Vena Cava Filters Market
28. North America Inferior Vena Cava Filters Market
29. USA Inferior Vena Cava Filters Market
30. Canada Inferior Vena Cava Filters Market
31. South America Inferior Vena Cava Filters Market
32. Brazil Inferior Vena Cava Filters Market
33. Middle East Inferior Vena Cava Filters Market
34. Africa Inferior Vena Cava Filters Market
36. Inferior Vena Cava Filters Market Competitive Landscape and Company Profiles
37. Inferior Vena Cava Filters Market Other Major and Innovative Companies
40. Inferior Vena Cava Filters Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Inferior Vena Cava Filters Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses inferior vena cava filters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for inferior vena cava filters? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The inferior vena cava filters market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Retrievable Inferior Vena Cava (IVC) Filters; Permanent Inferior Vena Cava (IVC) Filters2) By Material: Non-Ferromagnetic Materials; Ferromagnetic Materials
3) By Application: Treatment Of Venous Thromboembolism (VTE); Prevention Of Pulmonary Embolism (PE); Other Applications
4) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Retrievable IVC Filters: Optional Retrievable Filters; Temporary Filters2) By Permanent IVC Filters: Stainless Steel Filters; Titanium Filters
Companies Mentioned: B. Braun Melsungen AG; Boston Scientific Corporation; Cook Medical LLC; Medtronic plc; Teleflex Incorporated; Merit Medical Systems Inc.; Argon Medical Devices Inc.; Lifetech Scientific Corporation; Cordis Corporation; Becton Dickinson and Company; C. R. Bard Inc.; Penumbra Inc.; Terumo Corporation; Getinge AB; Philips Healthcare; Abbott Laboratories; AngioDynamics Inc.; Endologix LLC; MicroPort Scientific Corporation; Stryker Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Inferior Vena Cava Filters market report include:- B. Braun Melsungen AG
- Boston Scientific Corporation
- Cook Medical LLC
- Medtronic plc
- Teleflex Incorporated
- Merit Medical Systems Inc.
- Argon Medical Devices Inc.
- Lifetech Scientific Corporation
- Cordis Corporation
- Becton Dickinson and Company
- C. R. Bard Inc.
- Penumbra Inc.
- Terumo Corporation
- Getinge AB
- Philips Healthcare
- Abbott Laboratories
- AngioDynamics Inc.
- Endologix LLC
- MicroPort Scientific Corporation
- Stryker Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 6.29 Billion |
| Forecasted Market Value ( USD | $ 8.87 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
